Modified Cohort 1 (N = 450)a | Cohort 2 (N = 204)a | P-valueb | |
---|---|---|---|
Age, mean (SD) | 47.5 (14.6) | 54.6 (13.6) | < 0.001 |
Sex, n (%) | |||
Male | 182 (40.5) | 100 (49.0) | 0.043 |
Female | 267 (59.5) | 104 (51.0) | |
Lifetime antipsychotic exposure, mean (SD), years | 9.5 (9.0) | 15.9 (13.9) | < 0.0001 |
Psychiatric condition, n (%)c | |||
Schizophrenia or schizoaffective disorder | 146 (32.4) | 107 (52.5) | < 0.001 |
Mood or other psychiatric disorder | 354 (78.7) | 134 (65.7) | < 0.001 |
Severity of psychiatric condition, n (%) | |||
Normal, not ill | 47 (10.4) | 7 (3.4) | < 0.001 |
Minimally ill | 103 (22.9) | 27 (13.2) | |
Mildly ill | 111 (24.7) | 68 (33.3) | |
Moderately ill | 128 (28.4) | 67 (32.8) | |
Markedly ill | 43 (9.6) | 26 (12.7) | |
Severely ill | 16 (3.6) | 9 (4.4) | |
Among the most severely ill | 2 (0.4) | 0 | |
Overall health status, mean (SD)d | 4.2 (2.8) | 4.7 (2.8) | 0.031 |
Overall functional status, n (%)e | |||
Working/studying independently | 242 (53.8) | 66 (32.4) | < 0.001 |
Working/studying with assistance | 100 (22.2) | 44 (21.6) | |
Not working/studying | 108 (24.0) | 94 (46.1) |